blue water vaccines (BWV) Files For Up To $24M IPO

blue water vaccines (NYSE: BWV) files for up to $24,322,500 IPO.

The company describes itself as: "We are a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or proteins, with cross-reactive properties that enables the potential development of a universal flu vaccine. We are focused on developing novel vaccines that induce durable and long-term immunity. We believe that our pipeline and vaccine platform are synergistic for developing next generation preventive vaccines to improve both health outcomes and quality of life globally."

Maxim Group LLC will serve as sole underwriter.

You May Also Be Interested In

• YPF Energía Eléctrica S.A. files for proposed NYSE IPO
• Autonomix Medical raises $2.6M via warrant inducement agreement
• Quantum Corporation (QMCO) files for 13.81M share offering by selling stockholders